📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Effectiveness of BNT162b2 COVID-19 vaccination in prevention of hospitalisations and severe disease in adults with SARS-CoV-2 Delta (B.1.617.2) and Omicron (B.1.1.529) variant between June 2021 and July 2022: A prospective test negative case-control study. (2023)

First Author: Chatzilena A

Attributed to: Uncertainty Quantification for Expensive COVID-19 Simulation Models (UQ4Covid) funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.lanepe.2022.100552

PubMed Identifier: 36506791

Publication URI: http://europepmc.org/abstract/MED/36506791

Type: Journal Article/Review

Volume: 25

Parent Publication: The Lancet regional health. Europe

ISSN: 2666-7762